MedPath

NuvaRing

NUVARING (etonogestrel/ethinyl estradiol vaginal ring)

Approved
Approval ID

7e6f14df-1ce5-43fa-ad21-90bc4d74bc6c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

etonogestrel and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-4832
Application NumberNDA021187
Product Classification
M
Marketing Category
C73594
G
Generic Name
etonogestrel and ethinyl estradiol
Product Specifications
Route of AdministrationVAGINAL
Effective DateFebruary 9, 2012
FDA Product Classification

INGREDIENTS (5)

etonogestrelActive
Quantity: 11.7 mg in 1 1
Code: 304GTH6RNH
Classification: ACTIB
ethinyl estradiolActive
Quantity: 2.7 mg in 1 1
Code: 423D2T571U
Classification: ACTIM
ethylene-vinyl acetate copolymer (28% vinyl acetate)Inactive
Code: 8ILA5X28VS
Classification: IACT
ethylene-vinyl acetate copolymer (9% vinylacetate)Inactive
Code: 4OKC630HS6
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NuvaRing - FDA Drug Approval Details